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The	  Association	  between	  History	  of	  Gestational	  Diabetes	  Mellitus	  and	  Current	  Type	  2	  Diabetes	  
Status:	  An	  Examination	  of	  NHANES	  Data	  2011-­‐2014	  
	  
Background:	  Diabetes	  is	  a	  growing	  chronic	  disease	  that	  affects	  more	  than	  29	  million	  adults	  in	  
the	  United	  States	  and	  422	  million	  adults	  globally.	  Women	  with	  a	  history	  of	  gestational	  diabetes	  
(GDM)	  are	  identified	  to	  be	  at	  higher	  risk	  for	  developing	  subsequent	  type	  2	  diabetes	  mellitus	  
(T2DM).	  The	  prevalence	  of	  GDM	  varies	  based	  on	  the	  data	  collection	  method,	  response	  rate,	  
and	  diagnostic	  criteria.	  The	  aim	  of	  this	  study	  is	  to	  examine	  the	  association	  between	  history	  of	  
GDM	  diagnosis	  and	  current	  T2DM	  status	  and	  how	  the	  relationship	  differs	  based	  on	  the	  
participant’s	  age,	  race,	  and	  BMI.	  	  
	  
Methods:	  Data	  from	  the	  2011-­‐2012	  and	  2013-­‐2014	  National	  Health	  and	  Nutrition	  Examination	  
Surveys	  (NHANES)	  were	  analyzed	  to	  conduct	  a	  cross-­‐sectional	  study	  of	  4,006	  U.S.	  non-­‐pregnant	  
women	  ages	  20	  years	  and	  older	  with	  a	  history	  of	  prior	  pregnancy.	  The	  race/ethnicity	  of	  the	  
participants	  include	  non-­‐Hispanic	  Whites,	  non-­‐Hispanic	  Blacks,	  Mexican	  Americans,	  non-­‐
Hispanic	  Asians,	  and	  "Other"	  variables.	  Univariate	  and	  multivariate	  logistic	  regression	  analyses	  
were	  used	  to	  determine	  the	  association	  between	  history	  of	  GDM	  and	  current	  T2DM	  status	  
stratified	  by	  age,	  race,	  and	  BMI.	  	  
	  
Results:	  Three	  hundred	  and	  fifteen	  subjects	  from	  a	  sample	  size	  of	  4006	  were	  found	  to	  have	  a	  
history	  of	  GDM.	  Of	  the	  315	  participants	  with	  GDM,	  111	  (35.2%)	  were	  found	  to	  develop	  T2DM.	  
After	  controlling	  for	  age,	  race,	  and	  body	  mass	  index	  (BMI),	  women	  with	  a	  history	  of	  GDM	  were	  
found	  to	  be	  at	  greater	  odds	  of	  T2DM	  (OR=4.71;	  95%	  CI:	  3.52-­‐6.28)	  compared	  to	  women	  without	  
a	  history	  of	  GDM.	  A	  multivariate	  analysis	  was	  performed	  adjusting	  for	  other	  covariates	  such	  as	  
age,	  race,	  BMI,	  and	  cholesterol.	  When	  stratified	  by	  participant	  age,	  women	  between	  the	  ages	  of	  
20-­‐44	  years	  with	  a	  history	  of	  GDM	  were	  linked	  with	  an	  increased	  risk	  of	  T2DM	  (OR=	  3.02;	  95%	  
CI:	  1.88-­‐4.85).	  Overweight	  and	  obese	  women	  with	  a	  history	  of	  GDM	  have	  a	  2.5-­‐fold	  risk	  of	  
developing	  T2DM	  (OR=2.51;	  95%	  CI:	  1.49-­‐4.23).	  
	  
Discussion:	  This	  study	  provides	  further	  understanding	  and	  awareness	  on	  the	  role	  of	  GDM	  
during	  the	  subsequent	  risk	  for	  T2DM.	  Our	  study	  shows	  women	  between	  the	  ages	  of	  20	  and	  44	  
years	  and	  with	  elevated	  BMIs	  (25	  ≥	  kg/m2)	  are	  at	  increased	  risk	  of	  developing	  subsequent	  
T2DM.	  Findings	  suggest	  the	  need	  for	  health	  promotion	  and	  prevention	  efforts	  towards	  the	  
populations	  at	  risk.	  Early	  intervention	  post-­‐pregnancy	  and	  education	  may	  help	  prevent	  women	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Diabetes	  mellitus	  (DM)	  is	  the	  seventh	  leading	  cause	  of	  death	  in	  the	  United	  States.1	  The	  
increasing	  number	  of	  diabetics	  in	  the	  world	  is	  alarming	  because	  they	  are	  at	  an	  increased	  risk	  for	  
developing	  other	  health	  complications	  such	  as	  hypertension,	  cardiovascular	  disease,	  stroke,	  
dyslipidemia,	  blindness,	  eye	  disorders,	  neuropathy,	  renal	  disease,	  dental	  disease,	  amputations,	  
and	  complications	  of	  pregnancy.1	  Diabetes	  mellitus	  is	  a	  chronic	  metabolic	  disorder	  
characterized	  by	  elevated	  blood	  glucose	  levels,	  also	  known	  as	  hyperglycemia.1,2	  This	  condition	  
is	  a	  result	  of	  the	  inability	  of	  the	  pancreas	  to	  produce	  sufficient	  insulin	  (type	  1	  diabetes	  mellitus	  
or	  T1DM);	  the	  body’s	  incapability	  to	  properly	  use	  insulin	  (type	  2	  diabetes	  mellitus	  or	  T2DM);	  or	  
both.2	  Insulin	  is	  a	  hormone	  produced	  by	  the	  pancreas	  to	  regulate	  the	  blood	  glucose	  levels	  in	  the	  
blood	  by	  assisting	  in	  the	  movement	  of	  glucose,	  a	  simple	  sugar	  used	  for	  energy,	  into	  the	  cells	  of	  
our	  body.3	  
The	  global	  prevalence	  of	  diabetes	  in	  adults,	  aged	  18	  years	  and	  older,	  has	  escalated	  from	  
4.7%	  in	  1980	  to	  8.5%	  in	  2014.4	  According	  to	  the	  World	  Health	  Organization	  (WHO),	  the	  number	  
of	  adults	  living	  with	  DM	  globally	  was	  422	  million	  in	  2014.4	  The	  Centers	  for	  Disease	  Control	  and	  
Prevention	  (CDC)	  has	  reported	  more	  than	  29	  million	  adults	  living	  in	  the	  United	  States	  had	  
diabetes	  in	  2016.5	  Of	  those	  29	  million	  people,	  approximately	  8.1	  million	  are	  undiagnosed.5	  
Individuals	  of	  all	  ages	  are	  affected	  as	  the	  occurrence	  of	  diabetes	  continues	  to	  grow,	  including	  
women	  of	  childbearing	  age	  who	  are	  at	  greater	  risk	  of	  diabetes	  during	  pregnancy.	  	  
According	  to	  the	  National	  Institute	  of	  Diabetes	  and	  Digestive	  and	  Kidney	  Diseases	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(NIDDK),	  the	  possibility	  of	  developing	  type	  2	  diabetes	  can	  depend	  on	  the	  individual’s	  risk	  
factors.	  These	  risk	  factors	  include:6	  	  
● Overweight	  or	  obesity 
● Age	  45	  years	  or	  older 
● Family	  history	  of	  diabetes 
● Prediabetes	   
● Race/ethnicity	  is	  African	  American,	  Alaska	  Native,	  American	  Indian,	  Asian	  American,	  
Hispanic/Latino,	  Native	  Hawaiian,	  or	  Pacific	  Islander 
● Hypertension	  or	  high	  blood	  pressure 
● Low	  level	  of	  HDL	  cholesterol	  or	  a	  high	  level	  of	  triglycerides 
● Physical	  inactivity 
● History	  of	  heart	  disease	  or	  stroke 
● History	  of	  gestational	  diabetes 
Gestational	  diabetes	  mellitus	  (GDM)	  develops	  during	  pregnancy	  in	  women	  without	  a	  
known	  history	  of	  diabetes.	  Pregnancy	  increases	  the	  metabolic	  workload	  of	  the	  maternal	  
pancreas	  which	  results	  in	  increased	  insulin	  resistance	  and	  insulin	  insufficiency.2	  GDM	  affects	  1-­‐
14%	  of	  pregnant	  women	  annually	  in	  the	  U.S.7	  The	  prevalence	  of	  GDM	  varies	  based	  on	  the	  data	  
collection	  methods,	  low	  response	  rates,	  non-­‐random	  selection	  of	  women,	  and	  lack	  of	  
uniformity	  in	  the	  diagnostic	  criteria.8	  Women	  with	  a	  history	  of	  gestational	  diabetes	  are	  at	  an	  
increased	  risk	  of	  maternal	  and	  fetal	  complications.7,9	  Fetal	  and	  infant	  complications	  include:	  
macrosomia,	  birth	  trauma,	  premature	  birth,	  stillborn	  birth,	  hypoglycemia,	  and	  a	  higher	  risk	  of	  
developing	  type	  2	  diabetes	  later	  in	  life.9	  Maternal	  complications	  of	  GDM	  during	  pregnancy	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include:	  elevated	  blood	  pressure,	  preeclampsia,	  and	  a	  higher	  chance	  of	  needing	  a	  caesarean	  
section.7	  While	  gestational	  diabetes	  is	  often	  considered	  a	  temporary	  condition	  during	  
pregnancy,	  these	  women	  have	  an	  increased	  risk	  of	  having	  GDM	  with	  another	  pregnancy	  and	  a	  
greater	  risk	  of	  developing	  obesity	  and	  type	  2	  diabetes.7	  
	   Diabetes	  is	  diagnosed	  with	  three	  laboratory	  tests:	  glycohemoglobin	  (HbA1c),	  fasting	  
plasma	  glucose,	  and	  oral	  glucose	  tolerance	  test.	  Clinical	  guidelines	  changed	  in	  2010	  to	  include	  
glycohemoglobin	  (HbA1c)	  as	  a	  diagnostic	  test	  for	  diabetes.10	  The	  HbA1c	  test	  measures	  the	  
average	  glycated	  hemoglobin	  within	  the	  past	  three	  months.	  HbA1c	  levels	  were	  standardized	  to	  
define	  diabetes	  as	  ≥6.5%.10	  The	  fasting	  plasma	  glucose	  (FPG)	  test	  examines	  a	  blood	  sample	  
from	  an	  individual	  after	  fasting	  for	  a	  minimum	  of	  eight	  hours.	  According	  to	  the	  American	  
Diabetes	  Association	  (ADA)	  Guideline,	  a	  FPG	  ≥	  126	  mg/dL	  (7.0	  mmol/L)	  is	  classified	  as	  diabetic.11	  
The	  oral	  tolerance	  test	  (OGTT)	  consists	  of	  an	  eight	  hour	  fast.	  Diabetes	  is	  diagnosed	  if	  the	  2-­‐hour	  
blood	  glucose	  is	  ≥200	  mg/dL.11	  It	  is	  often	  recommended	  each	  test	  be	  repeated	  before	  a	  
definitive	  diagnosis	  is	  made.12	  
	   Prediabetes,	  also	  known	  as	  impaired	  glucose	  tolerance	  (IGT)	  or	  impaired	  fasting	  glucose	  
(IFG),	  is	  defined	  by	  having	  higher	  than	  normal	  blood	  glucose	  level	  but	  not	  high	  enough	  to	  be	  
diagnosed	  with	  type	  2	  diabetes.13	  The	  HbA1c	  range	  for	  prediabetes	  is	  5.7%	  -­‐6.4%.14	  An	  IFG	  level	  
between	  100	  mg/dL-­‐125	  mg/dL	  is	  considered	  pre-­‐diabetic.13	  Prediabetes	  can	  be	  diagnosed	  if	  
the	  OGTT	  is	  between	  140	  mg/dL-­‐199	  mg/dL.13	  Individuals	  diagnosed	  with	  prediabetes	  are	  at	  a	  
higher	  risk	  of	  developing	  type	  2	  diabetes	  .12-­‐15	  	  
1.2	  Purpose	  of	  the	  Study	  	  
	   Previous	  studies	  have	  been	  led	  to	  determine	  the	  association	  of	  T2DM	  and	  GDM.	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However	  there	  is	  limited	  information	  on	  the	  recent	  prevalence	  of	  the	  two	  with	  the	  growing	  
population.	  This	  study	  targets	  to	  examine	  the	  current	  diabetes	  status	  of	  women	  who	  have	  ever	  
been	  pregnant	  with	  and	  without	  a	  history	  of	  gestational	  diabetes.	  The	  purpose	  of	  this	  study	  is	  
to	  perform	  a	  cross-­‐sectional	  analysis	  using	  data	  from	  the	  2011-­‐2012	  and	  2013-­‐2014	  National	  
Health	  and	  Nutrition	  Examination	  Surveys	  (NHANES),	  a	  nationally	  representative	  survey,	  to	  
identify	  the	  association	  between	  history	  of	  gestational	  diabetes	  and	  the	  current	  diabetes	  
status.	  Women	  with	  a	  history	  of	  GDM	  are	  at	  an	  increased	  risk	  of	  developing	  T2DM.	  Therefore,	  it	  
is	  imperative	  we	  have	  a	  better	  understanding	  of	  the	  association	  between	  GDM	  and	  T2DM.	  This	  
study	  will	  identify	  higher	  risk	  populations	  of	  developing	  T2DM	  following	  a	  GDM	  diagnosis	  
during	  pregnancy.	  This	  study	  will	  further	  evaluate	  the	  distribution	  of	  history	  of	  GDM	  and	  
current	  T2DM	  status	  by	  age,	  race,	  and	  BMI.	  Demographic	  and	  metabolic	  characteristics,	  such	  as	  
history	  of	  hypertension,	  HDL,	  LDL,	  total	  cholesterol,	  and	  triglyceride,	  will	  also	  be	  included.	  	  
1.3	  Research	  Questions	  
1.	  What	  is	  the	  relationship	  between	  previous	  gestational	  diabetes	  diagnosis	  and	  current	  type	  2	  
diabetes	  status?	  









REVIEW	  OF	  THE	  LITERATURE	  
2.1	  Diabetes	  
T1DM	  was	  previously	  known	  as	  juvenile	  diabetes	  and	  insulin-­‐dependent	  diabetes	  
because	  it	  develops	  primarily	  in	  children	  and	  requires	  daily	  administration	  of	  insulin.	  T1DM	  is	  
characterized	  by	  an	  inadequate	  production	  of	  insulin	  due	  to	  idiopathic	  or	  autoimmune	  
destruction	  of	  β-­‐cells.2	  People	  living	  with	  T1DM	  account	  for	  5-­‐10%	  of	  the	  disease.2	  
T2DM	  was	  previously	  known	  as	  non-­‐insulin-­‐dependent	  or	  adult-­‐onset	  diabetes.	  T2DM	  is	  
characterized	  by	  your	  body’s	  inability	  to	  properly	  use	  insulin.	  Insulin	  resistance	  can	  develop	  if	  
the	  body’s	  target	  cells	  become	  resistant	  to	  the	  effects	  of	  insulin.2	  These	  target	  cells	  become	  less	  
responsive	  to	  insulin	  and	  require	  more	  insulin	  in	  order	  to	  have	  its	  typical	  effects.	  To	  
compensate,	  the	  pancreas	  will	  increase	  its	  insulin	  production	  until	  the	  pancreas	  is	  unable	  to	  
meet	  the	  body’s	  demand.	  This	  causes	  glucose	  to	  build	  up	  and	  blood	  sugar	  levels	  to	  elevate.15	  
T2DM	  accounts	  for	  90-­‐95%	  of	  all	  diabetics.2	  Menke	  et	  al.	  conducted	  a	  cross-­‐sectional	  study	  
using	  NHANES	  1988-­‐2012	  to	  examine	  the	  prevalence	  and	  trends	  of	  diabetes	  among	  adults	  in	  
the	  United	  States.16	  The	  authors	  determined	  there	  was	  a	  12-­‐14%	  prevalence	  of	  diabetes	  in	  the	  
population	  from	  2011	  to	  2012.16	  	  
2.2	  Risk	  Factors	  for	  DM	  
	  	   Risk	  factors	  for	  diabetes	  comprise	  of	  both	  non-­‐modifiable	  and	  modifiable	  risk	  factors.	  
Non-­‐modifiable	  risk	  factors	  are	  factors	  outside	  our	  control	  and	  cannot	  be	  changed.17	  Non-­‐
modifiable	  risk	  factors	  of	  diabetes	  include:	  family	  history	  of	  diabetes,	  age,	  race/ethnicity,	  and	  
history	  of	  gestational	  diabetes.17	  The	  American	  Heart	  Association	  categorizes	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overweight/obesity,	  physical	  inactivity,	  hypertension,	  and	  abnormal	  cholesterol/	  lipid	  levels	  as	  
modifiable	  risk	  factors.17	  Modifiable	  risk	  factors	  can	  be	  changed	  with	  lifestyle	  choices	  to	  reduce	  
the	  risk	  of	  developing	  T2DM.17	  	  
	   Age:	  The	  United	  States	  is	  an	  aging	  population.	  The	  number	  of	  people	  ages	  65	  years	  and	  
older	  has	  steadily	  increased	  since	  the	  1960s18.	  In	  2014,	  there	  were	  46	  million	  people	  ages	  65	  
years	  and	  older	  living	  in	  the	  United	  States	  and	  is	  projected	  to	  double	  by	  the	  year	  2060.18	  With	  
this	  said,	  the	  risk	  for	  developing	  diabetes	  increases	  with	  age.19	  Older	  adults	  may	  be	  at	  a	  higher	  
risk	  because	  their	  metabolism	  slows	  down,	  functionality	  decreases,	  and	  body	  composition	  
changes.20	  Type	  2	  diabetes	  generally	  occurs	  after	  the	  age	  of	  45	  years.17	  According	  to	  the	  2017	  
National	  Diabetes	  Statistics	  Report,	  approximately	  355,000	  new	  cases	  of	  diabetes	  in	  2015	  were	  
among	  adults	  aged	  45-­‐64	  years.21	  The	  average	  age	  of	  T2DM	  onset	  is	  60	  years	  of	  age	  with	  a	  
prevalence	  rate	  of	  15%	  among	  people	  over	  65	  years	  of	  age.	  22	  
Race:	  The	  diversity	  of	  race	  and	  ethnicity	  plays	  a	  role	  in	  he	  rise	  in	  diabetes	  prevalence.	  In	  
2014,	  more	  than	  97%	  of	  the	  total	  population	  identified	  themselves	  as	  one	  race.	  Race	  categories	  
were	  broken	  down	  to:	  62.2%	  as	  non-­‐Hispanic	  White,	  13.2%	  as	  Black	  or	  African	  American,	  5.4	  %	  
as	  Asian,	  and	  17.4%	  as	  Hispanic.23	  According	  to	  the	  2011	  US	  Census,	  the	  Hispanic	  population	  
grew	  by	  43%	  from	  2000	  to	  2010.	  Asian	  Americans	  increased	  by	  43%	  from	  2000	  to	  2010,	  making	  
them	  the	  fastest	  growing	  race	  in	  the	  US.	  24	  While	  the	  non-­‐Hispanic	  White	  population	  continues	  
to	  grow,	  its	  proportion	  of	  the	  population	  has	  declined	  in	  the	  same	  year	  reference	  from	  69%	  to	  
64%.24	  The	  prevalence	  of	  diabetes	  differs	  between	  race	  and	  ethnicities.	  According	  to	  the	  
American	  Diabetes	  Association,	  the	  rates	  of	  diagnosed	  diabetes	  by	  race/ethnic	  background	  are	  
of	  the	  following:	  non-­‐Hispanic	  Whites	  (7.4%),	  Asian	  Americans	  (8.0%),	  Hispanics	  (12.1%),	  non-­‐
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Hispanic	  Blacks	  (12.7%),	  and	  American	  Indian/Alaskan	  Natives	  (15.1%).5	  Genetics	  can	  account	  
for	  increase	  prevalence	  of	  T2DM	  in	  minority	  groups.25	  There	  is	  ongoing	  research	  on	  identifying	  
the	  genes	  linking	  to	  diabetes.26	  As	  of	  2010,	  genome-­‐wide	  association	  studies	  have	  identified	  
approximately	  40	  loci	  for	  which	  variants	  increase	  risk	  of	  T2DM	  .26	  Previous	  studies	  also	  show	  
diabetes	  disparities	  among	  racial/ethnic	  minorities	  in	  health	  outcomes	  and	  quality	  of	  life.27	  
Some	  of	  the	  disparity	  is	  due	  to	  lack	  of	  awareness,	  treatment	  and	  quality	  of	  care	  in	  the	  minority	  
groups.28	  For	  example,	  a	  population	  based	  assessment	  found	  Puerto	  Rican	  adults	  with	  DM	  were	  
less	  likely	  than	  non-­‐Hispanic	  Whites	  to	  receive	  annual	  glycohemoglobin	  testing	  (73%	  versus	  
85%).29	  	  
BMI:	  The	  prevalence	  of	  obesity	  in	  the	  U.S.	  is	  increasing.	  The	  World	  Health	  Organization	  
defines	  overweight	  and	  obesity	  as	  the	  abnormal	  or	  excessive	  fat	  accumulation	  that	  may	  impair	  
health.30	  Body	  mass	  index	  (BMI)	  is	  commonly	  used	  as	  a	  screening	  tool	  to	  classify	  overweight	  
and	  obesity	  in	  adults.	  BMI	  is	  calculated	  from	  a	  person’s	  weight	  in	  kilograms	  divided	  by	  the	  
square	  height	  in	  meters	  (kg/m2).30	  Weight	  is	  classified	  as:	  31	  
● Underweight	  if	  BMI	  is	  <	  18.5	  kg/m2 
● Normal	  if	  BMI	  is	  18.5	  to	  <	  25	  kg/m2 
● Overweight	  if	  BMI	  is	  25	  to	  <30	  kg/m2 
● Obese	  if	  BMI	  is	  30	  kg/m2	  or	  higher 
● Extremely	  obese	  if	  BMI	  is	  ≥	  40	  kg/m2 
According	  to	  the	  NIDDK,	  35.7%	  of	  adults	  aged	  20	  and	  older	  are	  obese32,	  and	  6.3%	  are	  
considered	  to	  have	  extreme	  obesity.33	  Being	  overweight	  or	  obese	  is	  a	  main	  risk	  factor	  for	  
T2DM.34	  A	  cross-­‐sectional	  study	  was	  conducted	  in	  2008	  to	  examine	  the	  risk	  of	  diabetes	  among	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people	  20-­‐64	  years	  of	  age	  with	  BMIs	  of	  25-­‐29	  kg/m2	  and	  >30	  kg/m2.35	  The	  authors	  concluded	  
more	  than	  50%	  of	  the	  women	  could	  have	  avoided	  diabetes	  by	  maintaining	  a	  normal	  weight.35	  A	  
cross-­‐sectional	  examination	  of	  NHANES	  1999-­‐2008	  was	  conducted	  to	  examine	  the	  prevalence	  
and	  trend	  of	  obesity	  and	  overweight	  in	  the	  US.	  The	  prevalence	  of	  obesity	  was	  over	  30%	  for	  
every	  age	  and	  sex	  group.	  The	  age-­‐adjusted	  prevalence	  of	  diabetes	  in	  women	  was	  35.5%.36	  
Hypertension	  and	  Cholesterol:	  Blood	  pressure	  is	  measured	  by	  two	  numbers.	  The	  first	  
number,	  called	  the	  systolic	  blood	  pressure	  (SBP),	  measures	  the	  pressure	  in	  the	  blood	  vessel	  
when	  the	  heart	  beats.37	  The	  second	  number,	  called	  the	  diastolic	  blood	  pressure	  (DBP),	  
measures	  the	  pressure	  in	  the	  blood	  vessels	  when	  the	  heart	  is	  at	  rest	  between	  beats.	  37	  An	  
individual	  is	  diagnosed	  with	  high	  blood	  pressure,	  hypertension,	  if	  blood	  is	  pumping	  through	  the	  
heart	  and	  blood	  vessels	  with	  too	  much	  force.38	  The	  American	  Heart	  Association	  defines	  blood	  
pressure	  levels	  above	  140/90	  mmHg	  as	  hypertensive.39	  Cholesterol	  is	  made	  up	  of	  a	  group	  of	  fat	  
called	  low-­‐density-­‐lipoprotein	  (LDL)	  and	  high-­‐density-­‐lipoprotein	  (HDL).40	  LDL	  makes	  up	  the	  
majority	  of	  cholesterol	  in	  the	  blood	  and	  can	  cause	  plaque	  buildup	  in	  the	  arteries.40	  HDL	  helps	  
remove	  cholesterol	  from	  our	  arteries.41	  Triglyceride	  is	  another	  type	  of	  fat	  found	  in	  the	  body	  that	  
is	  used	  for	  energy.40	  Total	  cholesterol	  is	  made	  up	  of	  the	  combined	  numbers	  of	  LDL,	  HDL,	  and	  
triglyceride.	  Cholesterol	  is	  classified	  as:41-­‐42	  
	   HDL	   LDL	   Triglyceride	   Total	  Cholesterol	  
Desirable	   >	  60	  mg/dL	   <	  100	  mg/dL	   <	  200	  mg/dL	   <	  150mg/dL	  
Borderline	  High	   40-­‐59	  mg/dL	   100-­‐159	  mg/dL	   200-­‐239	  mg/dL	   150-­‐199	  mg/dL	  
High	   __	   ≥	  160	  mg/dL	   ≥	  240	  mg/dL	   ≥	  200	  mg/dL	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Low	   <40	  mg/dL	   __	   __	   __	  
	  
Diabetes	  tends	  to	  lower	  HDL	  levels	  and	  raise	  LDL	  and	  triglyceride	  levels.6	  The	  
significance	  of	  correlation	  between	  hypertension	  and	  diabetes	  is	  unknown,	  but	  approximately	  
26%	  of	  adults	  have	  multiple	  chronic	  conditions.38,43	  Song	  et	  al.	  analyzed	  the	  trend	  of	  concurrent	  
diabetes,	  hypertension,	  and	  hypercholesterolemia	  using	  NHANES	  1999-­‐2012.43	  The	  prevalence	  
of	  concurrent	  diabetes,	  hypertension	  and	  hypercholesterolemia	  increased	  from	  3%	  in	  1999-­‐
2000	  to	  6.3%	  in	  2011-­‐2012.43	  
2.3	  Gestational	  Diabetes	  
The	  American	  Diabetes	  Association	  defines	  gestational	  diabetes	  mellitus	  (GDM)	  as	  “any	  
degree	  of	  glucose	  intolerance	  with	  onset	  or	  first	  recognition	  during	  pregnancy.”44	  GDM	  is	  
associated	  with	  increased	  maternal	  and	  infant	  complications	  such	  as	  increased	  cesarean	  
delivery,	  infant	  macrosomia,	  infant	  respiratory	  distress,	  neonatal	  hypoglycemia,	  and	  increased	  
risk	  for	  T2DM	  for	  both	  mother	  and	  child.45	  GDM	  complicates	  approximately	  4-­‐7%	  of	  
pregnancies	  annually	  in	  the	  United	  States.27	  According	  to	  the	  CDC,	  the	  incidence	  rate	  of	  
diagnosed	  diabetes	  has	  increased	  for	  women	  ages	  18-­‐44	  and	  45-­‐64	  years.	  Among	  women	  ages	  
18-­‐44	  years,	  the	  incidence	  rate	  had	  increased	  from	  2.2	  to	  3.5	  per	  1,000	  population	  from	  the	  
year	  1997	  to	  2014.	  During	  the	  same	  time	  period,	  the	  incidence	  rate	  of	  diagnosed	  diabetes	  for	  
women	  ages	  45-­‐64	  increased	  from	  7.0	  to	  10.0	  per	  1,000	  population.46	  	  
The	  prevalence	  of	  GDM	  is	  growing.	  Correa	  et	  al.9	  conducted	  a	  study	  using	  NIS,	  the	  
largest	  publicly	  available	  inpatient	  healthcare	  database,	  to	  describe	  the	  trends	  in	  diabetes	  
prevalence	  among	  delivery	  hospitalization	  in	  the	  United	  States	  from	  1993	  to	  2009.47	  Between	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the	  given	  years,	  the	  authors	  discovered	  an	  increase	  in	  prevalence	  of	  GDM	  from	  3.09	  to	  5.57	  per	  
100	  deliveries.9	  A	  2014	  analysis	  conducted	  by	  the	  CDC	  examined	  GDM	  as	  reported	  on	  birth	  
certificates	  and	  Pregnancy	  Risk	  Assessment	  Monitoring	  System	  (PRAMS)	  questionnaires.	  The	  
analysis	  reported	  the	  prevalence	  of	  GDM	  was	  as	  high	  as	  9.2%.7	  	  
	   Women	  who	  have	  a	  family	  or	  personal	  history	  of	  prediabetes	  or	  gestational	  diabetes,	  
are	  obese,	  older	  than	  25	  years	  of	  age,	  of	  non-­‐White	  race	  (African,	  American	  Indian,	  Asian,	  
Hispanic,	  or	  Pacific	  Islander),	  or	  have	  a	  family	  or	  personal	  health	  history	  of	  prediabetes	  or	  
gestational	  diabetes	  are	  at	  an	  increased	  risk	  for	  developing	  gestational	  diabetes.44	  	  
	   Age:	  The	  risk	  of	  GDM	  increases	  with	  advancing	  age.20,28	  A	  retrospective	  study	  conducted	  
between	  1988	  and	  2000	  revealed	  a	  strong	  association	  between	  advancing	  maternal	  age	  and	  the	  
development	  of	  GDM.	  The	  mean	  age	  of	  the	  women	  who	  developed	  GDM	  was	  greater	  than	  the	  
comparison	  group	  (29.6±	  5.2	  years	  versus	  26.8	  ±	  5.1	  years).48	  In	  another	  study,	  the	  pregnancy	  
outcome	  in	  women	  ages	  45	  year	  and	  older	  was	  evaluated.	  The	  study	  showed	  the	  rate	  of	  GDM	  
among	  women	  45	  years	  and	  older	  was	  higher	  in	  comparison	  to	  the	  whole	  sample	  (17.0%	  versus	  
5.6%).49	  	  
Race:	  GDM	  also	  differs	  by	  race/ethnicity.	  In	  2004,	  the	  percentages	  of	  live	  births	  were	  
56%,	  14%,	  23%	  and	  6%	  to	  non-­‐Hispanic	  White,	  Hispanic,	  non-­‐Hispanic	  Black	  Hispanic,	  and	  non-­‐
Hispanic	  Asians,	  respectively.50	  From	  1990	  to	  2001,	  a	  trend	  study	  using	  birth	  certificates	  saw	  a	  
significant	  GDM	  increase	  in	  all	  major	  racial/ethnic	  groups	  except	  non-­‐Hispanic	  White	  women.51	  
Asian	  American	  and	  Hispanics	  had	  a	  significantly	  higher	  prevalence	  of	  GDM	  compared	  to	  non-­‐
Hispanic	  White.52	  
BMI:	  GDM	  risk	  increases	  with	  increasing	  body	  mass	  index	  (BMI).	  Kim	  et	  al.	  used	  the	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Pregnancy	  Risk	  Assessment	  Monitoring	  System	  to	  calculate	  the	  percentage	  of	  GDM	  attributable	  
to	  overweight	  and	  obesity.	  They	  discovered	  the	  overall	  population-­‐attributable	  fraction	  for	  
overweight,	  obese,	  and	  extremely	  obese	  was	  46.2%.53	  The	  risk	  of	  GDM	  can	  be	  reduced	  with	  
diet	  and	  exercise.	  There	  have	  been	  several	  studies	  conducted	  in	  the	  past	  that	  evaluated	  weight	  
gain,	  diet,	  and	  physical	  activity	  in	  association	  to	  GDM.	  A	  descriptive-­‐comparison	  study	  was	  
conducted	  to	  determine	  the	  dietary	  style	  and	  physical	  activity	  level	  of	  women	  with	  and	  without	  
GDM.54	  In	  this	  study,	  the	  authors	  found	  a	  significant	  difference	  in	  the	  mean	  moderate	  activity	  
duration	  between	  the	  healthy	  pregnant	  women	  and	  women	  with	  gestational	  diabetes.	  
Moderate	  to	  intense	  physical	  activity	  can	  lead	  to	  a	  27%	  reduction	  of	  developing	  elevated	  blood	  
glucose	  levels	  during	  pregnancy.54	  	  
Pregnant	  women	  with	  any	  of	  the	  risk	  factors	  of	  diabetes	  listed	  above	  are	  recommended	  
get	  testing	  for	  undiagnosed	  T2DM	  at	  their	  first	  prenatal	  visit.	  Gestational	  diabetes	  is	  generally	  
diagnosed	  in	  the	  second	  or	  third	  trimester.	  Pregnant	  women	  without	  prior	  knowledge	  of	  
diabetes	  are	  advised	  to	  get	  testing	  for	  GDM	  between	  24-­‐28	  weeks	  of	  gestation.	  In	  the	  United	  
States,	  the	  most	  clinical	  test	  is	  the	  two-­‐step	  approach.55	  Five	  to	  ten	  percent	  of	  women	  continue	  
to	  have	  hyperglycemia	  after	  delivery.44	  	  
The	  ADA	  recommends	  women	  with	  GDM	  to	  get	  tested	  for	  the	  oral	  glucose	  tolerance	  
test	  (OGTT)	  at	  the	  6-­‐	  to	  12-­‐week	  postpartum	  visit.	  If	  the	  OGTT	  is	  normal,	  ADA	  recommends	  
these	  women	  get	  tested	  again	  every	  one	  to	  three	  years.11	  Oza-­‐Frank	  et	  al.	  used	  data	  from	  the	  
Pregnancy	  Risk	  Assessment	  Monitoring	  System	  (PRAMS)	  2009-­‐2010,	  a	  population	  based	  survey,	  
to	  measure	  the	  frequency	  of	  postpartum	  diabetes	  testing	  among	  women	  with	  previous	  GDM.56	  
The	  study	  disclosed	  only	  51.7%	  of	  PRAM	  respondents	  with	  GDM	  attended	  a	  postpartum	  visit	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and	  actually	  had	  the	  postpartum	  test	  for	  diabetes.56	  Nabuco	  et	  al.	  studied	  the	  accuracy	  of	  the	  
OGTT	  48-­‐72	  hours	  postpartum	  in	  attempts	  to	  increase	  the	  number	  of	  postpartum	  screening.	  
The	  authors	  concluded	  early	  OGTT	  testing	  is	  helpful	  in	  identifying	  the	  women	  who	  require	  the	  
6-­‐week	  postpartum	  testing.57	  
A	  study	  was	  previously	  conducted	  in	  Sydney,	  Australia	  to	  understand	  the	  relationship	  
between	  T2DM	  and	  GDM.	  In	  this	  study,	  medical	  records	  of	  women	  with	  T2DM	  in	  pregnancy	  
were	  reviewed	  retrospectively	  to	  assess	  whether	  these	  women	  had	  GDM.	  The	  data	  indicated	  
that	  44%	  of	  women	  with	  T2DM	  in	  pregnancy	  had	  a	  history	  of	  previous	  GDM.58	  Women	  with	  a	  
history	  of	  GDM	  have	  a	  30-­‐84%	  increased	  risk	  of	  developing	  GDM	  in	  subsequent	  pregnancies.58	  
It	  is	  important	  to	  understand	  the	  prevalence	  of	  GDM	  in	  the	  most	  recent	  years	  in	  order	  to	  















3.1	  Data	  Source	  
	   Data	  was	  obtained	  from	  the	  National	  Health	  and	  Nutrition	  Examination	  Survey	  
(NHANES),	  a	  survey	  to	  assess	  the	  health	  and	  nutritional	  status	  of	  people	  living	  in	  the	  United	  
States.59	  Health	  interviews	  are	  conducted	  in	  the	  respondents’	  home	  and	  physical	  examinations	  
are	  conducted	  in	  specially	  designed	  mobile	  centers.	  The	  survey	  takes	  a	  nationally	  
representative	  sample	  of	  5,000	  people	  annually	  and	  reports	  every	  2	  years.	  Data	  was	  obtained	  
from	  two	  two-­‐year	  cycles,	  NHANES	  2011-­‐2012	  and	  2013-­‐2014.	  NHANES	  is	  a	  publically	  available	  
secondary	  data	  source	  and	  is	  currently	  approved	  by	  the	  IRB	  as	  not	  human	  subject	  research.60-­‐61	  




	   Age:	  Participants	  between	  the	  ages	  of	  1	  and	  79	  years	  at	  the	  time	  of	  screen	  were	  
reported	  in	  terms	  of	  age	  in	  years.	  Those	  who	  are	  80	  years	  and	  older	  were	  coded	  as	  “80.”	  The	  
age	  was	  calculated	  based	  on	  the	  participant’s	  date	  of	  birth	  or	  the	  age	  reported.	  Women	  ages	  20	  
year	  and	  older	  were	  included	  in	  the	  analysis.	  	  
Race:	  A	  new	  variable	  was	  added	  to	  the	  NHANES	  survey	  in	  2011	  to	  include	  non-­‐Hispanic	  
Asians.	  Prior	  to	  2011,	  Asians	  were	  included	  in	  the	  “other”	  category.	  The	  NHANES	  2011-­‐2014	  
sample	  design	  included	  an	  oversample	  of	  Asian	  Americans	  in	  addition	  to	  the	  ongoing	  
oversampling	  of	  non-­‐Hispanic	  Black,	  and	  persons	  60	  years	  and	  over.60	  The	  oversampling	  of	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these	  subgroups	  increased	  the	  reliability	  of	  the	  estimates	  of	  health	  status	  indicators	  for	  these	  
populations.60	  Even	  with	  the	  oversampling,	  Asian	  and	  Mexican	  Americans	  constitute	  11-­‐17	  
percent	  of	  the	  un-­‐weighted	  examined	  sample	  for	  NHANES	  2011-­‐2014.	  The	  NHANES	  Analytic	  
Guidelines	  advised	  caution	  when	  performing	  analysis	  due	  to	  limited	  sample	  size	  and	  suggested	  
it	  might	  be	  necessary	  to	  examine	  all	  four	  years	  for	  reliable	  analysis.59-­‐61	  The	  categories	  of	  the	  
self-­‐identified	  race	  were:	  Mexican	  American,	  other	  Hispanics,	  non-­‐Hispanic	  White,	  non-­‐Hispanic	  
Black,	  non-­‐Hispanic	  Asian,	  and	  “Other”	  Race.	  There	  were	  no	  missing	  values	  for	  race.	  For	  the	  
purpose	  of	  the	  study,	  Mexican	  American	  and	  other	  Hispanics	  were	  combined	  to	  create	  five	  race	  
categories:	  Mexican	  American,	  non-­‐Hispanic	  White,	  non-­‐Hispanic	  Black,	  non-­‐Hispanic	  Asian,	  
and	  Other.	  
Education:	  This	  variable	  will	  inform	  us	  of	  the	  highest	  level	  of	  education	  completed	  by	  
adult	  participants,	  20	  years	  and	  older.	  The	  categories	  of	  education	  was	  divided	  into:	  less	  than	  
9th	  grade,	  9-­‐11th	  grade,	  high	  school	  graduate/GED	  or	  equivalent,	  some	  college	  or	  AA	  degree,	  
or	  college	  graduate	  or	  above.	  Participants	  that	  refused	  to	  answer	  or	  did	  not	  know	  were	  coded	  
as	  “missing”.	  	  
Income:	  Income	  was	  based	  on	  the	  total	  annual	  household	  income	  based	  on	  dollar	  
range.	  If	  a	  household	  was	  comprised	  of	  a	  single	  family	  or	  individual,	  the	  reported	  family	  income	  
was	  used	  as	  household	  income.	  	  
Pregnancy	  
	   Information	  of	  variables	  related	  to	  pregnancy	  was	  gathered	  in	  the	  reproductive	  health	  
questionnaire.	  This	  dataset	  contains	  records	  for	  variables	  related	  to	  pregnant	  for	  women	  
between	  the	  ages	  of	  20	  and	  44	  years.	  Women	  19	  years	  old	  or	  younger	  and	  women	  over	  45	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years	  were	  excluded	  from	  this	  dataset	  due	  to	  disclosure	  risks.	  Questions	  used	  from	  the	  
reproductive	  health	  questionnaire	  were,	  “Have	  you	  ever	  been	  pregnant?”,	  “Are	  you	  pregnant	  
now?”,	  “During	  pregnancy,	  were	  you	  ever	  told	  by	  a	  doctor	  or	  other	  health	  professional	  you	  had	  
diabetes,	  sugar	  diabetes	  or	  gestational	  diabetes	  (not	  including	  diabetes	  that	  you	  have	  known	  
before	  the	  pregnancy)?”,	  and	  “How	  old	  were	  you	  when	  you	  were	  first	  told	  you	  had	  diabetes	  
during	  pregnancy?”.	  Women	  with	  a	  history	  of	  pregnancy	  were	  included	  in	  this	  study.	  
Participants	  that	  were	  currently	  pregnant	  at	  the	  time	  of	  interview	  and	  examination	  were	  
excluded.	  Individuals	  that	  answered	  yes	  to	  the	  “during	  pregnancy,	  were	  told	  by	  a	  doctor	  or	  
other	  health	  professional	  you	  have	  diabetes”	  question	  were	  coded	  for	  having	  a	  positive	  history	  
of	  GDM.	  	  
Diabetes	  
	   The	  diagnosis	  of	  diabetes	  was	  defined	  based	  on	  the	  self-­‐reported	  response	  to	  the	  
diabetes	  questionnaire	  and	  laboratory	  variables.	  Questions	  obtained	  in	  the	  diabetes	  
questionnaire	  were	  “{Other	  than	  during	  pregnancy},	  have	  you	  ever	  been	  told	  by	  a	  doctor	  of	  
health	  professional	  that	  you	  have	  diabetes	  or	  sugar	  diabetes?”,	  “	  Have	  you	  ever	  been	  told	  by	  a	  
doctor	  or	  other	  health	  professional	  that	  you	  have	  prediabetes,	  impaired	  fasting	  glucose,	  
impaired	  glucose	  tolerance,	  borderline	  diabetes	  or	  that	  your	  blood	  sugar	  is	  higher	  than	  normal	  
but	  not	  high	  enough	  to	  be	  called	  diabetes	  or	  sugar	  diabetes?”,	  “How	  old	  were	  you	  when	  a	  
doctor	  or	  other	  health	  professional	  first	  told	  you	  that	  you	  had	  diabetes	  or	  sugar	  diabetes?”,	  
“Are	  you	  now	  taking	  diabetic	  pills	  to	  lower	  your	  blood	  sugar?”.	  The	  laboratory	  measures	  that	  
tested	  for	  diabetes	  were	  Glycohemoglobin	  (%),	  Two	  Hour	  Glucose	  (OGTT)	  (mg/dL)	  and	  Fasting	  
Plasma	  Glucose	  (mg/dL).	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BMI	  
	   NHANES	  uses	  body	  measures	  data	  to	  monitor	  and	  estimate	  the	  prevalence	  of	  
overweight	  and	  obesity	  in	  the	  population.	  Body	  mass	  index	  (BMI)	  was	  calculated	  as	  weight	  in	  
kilograms	  divided	  by	  height	  in	  meters	  squared	  (kg/m2).	  A	  BMI	  of	  24.9	  kg/m2	  or	  less	  was	  
considered	  normal	  weight.	  BMI	  of	  25.0-­‐29.9	  kg/m2	  and	  30.0	  kg/m2	  and	  above,	  were	  considered	  
overweight	  and	  obese,	  respectively.32	  
Cholesterol	  
	   The	  variables	  related	  to	  cholesterol	  were	  obtained	  from	  the	  laboratory	  variable	  list.	  The	  
variables	  examined	  were:	  Direct-­‐HDL-­‐Cholesterol	  (mg/dL),	  LDL-­‐Cholesterol	  (mg/dL),	  Triglyceride	  
(mg/dL),	  and	  Total	  Cholesterol	  (mg/dL).	  HDL-­‐cholesterol	  was	  categorized	  as	  normal	  if	  HDL	  was	  
greater	  than	  or	  equal	  to	  40	  mg/dL	  and	  elevated	  if	  HDL	  was	  less	  than	  40	  mg/	  dL.	  A	  LDL	  level	  of	  
160	  mg/dL	  or	  lower	  was	  classified	  as	  normal.	  Total	  cholesterol	  of	  less	  than	  240	  mg/dL	  and	  
triglyceride	  of	  less	  than	  200	  mg/dL	  were	  considered	  within	  the	  normal	  range.	  	  
3.3	  Inclusion	  and	  Exclusion	  Criteria	  
	   As	  this	  is	  a	  study	  focused	  on	  previous	  gestational	  diabetes	  status,	  males	  were	  excluded.	  
The	  participants	  must	  have	  responded	  yes	  to	  the	  question	  “during	  pregnancy,	  was	  told	  you	  had	  
diabetes”.	  Women	  reporting	  pregnancy	  at	  the	  time	  of	  the	  exam	  was	  excluded	  from	  the	  study.	  
The	  responses	  from	  the	  diabetes	  questionnaire	  were	  used	  to	  determine	  history	  of	  diabetes.	  
Diabetes	  was	  diagnosed	  if	  the	  participants	  responded	  yes	  to	  the	  “told	  by	  a	  doctor	  or	  health	  
professional	  you	  have	  diabetes”	  question	  or	  to	  the	  “taking	  diabetic	  pills	  to	  lower	  your	  blood	  
sugar”	  question.	  Undiagnosed	  cases	  were	  classified	  as	  having	  diabetes	  if	  one	  of	  the	  laboratory	  
measures	  for	  diabetes	  was	  met:	  a	  glycohemoglobin	  of	  6.5%	  or	  higher,	  a	  fasting	  plasma	  glucose	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of	  126	  mg/dL	  or	  higher,	  or	  a	  two-­‐hour	  glucose	  tolerance	  test	  of	  200	  mg/dL	  or	  higher.11	  
Participants	  that	  reported	  age	  diagnosed	  with	  diabetes	  prior	  to	  age	  diagnosed	  with	  gestational	  
diabetes	  were	  excluded.	  	  
3.4	  Statistical	  Procedures	  
Statistical	  Analysis	  System	  (SAS)	  version	  9.4	  was	  used	  to	  prepare	  and	  analyze	  the	  data.	  
Descriptive	  statistics	  were	  derived	  from	  the	  demographic	  and	  metabolic	  variables	  using	  SAS.	  
Univariate	  and	  multivariate	  logistic	  regression	  analyses	  were	  performed	  on	  women	  with	  and	  
without	  a	  history	  of	  gestational	  diabetes	  to	  determine	  association	  with	  current	  diabetes	  status,	  
age,	  race,	  BMI,	  and	  cholesterol.	  Ages	  20-­‐44	  years,	  non-­‐Hispanic	  Whites,	  and	  BMI	  <	  25	  kg/m2	  
were	  used	  as	  the	  reference	  groups.	  Multivariate	  logistic	  regression	  analysis	  was	  performed	  and	  
stratified	  by	  GDM	  history	  and	  current	  T2DM	  diagnosis	  by	  age,	  race,	  and	  BMI.	  A	  p-­‐value	  <0.05	  














4.1	  Descriptive	  Statistics	  
	   The	  sample	  size	  of	  this	  study	  was	  n=4,006,	  of	  which	  n=315	  participants	  (7.9%)	  had	  a	  
history	  of	  GDM.	  The	  basic	  characteristics	  of	  the	  study	  sample	  based	  on	  GDM	  history	  are	  shown	  
in	  Table	  1.	  Compared	  to	  women	  without	  a	  known	  history	  of	  GDM,	  the	  women	  with	  a	  history	  of	  
GDM	  had	  significantly	  higher	  percentages	  in	  the	  20-­‐44	  year	  age	  category	  (56.2%	  versus	  32.1%;	  
p<0.0001),	  BMI	  ≥	  25	  kg/m2	  (80.0%	  versus	  70.9%;	  p=0.0006),	  HDL	  <	  40	  mg/dL	  category	  (19.3%	  
versus	  9.8%;	  p<0.0001),	  and	  triglyceride	  ≥	  200	  mg/dL	  category	  (18.1%	  versus	  8.9%;	  p=0.0003).	  
In	  comparison,	  there	  was	  a	  significantly	  greater	  percentage	  of	  women	  without	  a	  known	  history	  
of	  GDM	  in	  the	  70	  years	  and	  older	  age	  category	  (20.1%	  versus	  3.2%;	  p<0.0001).	  The	  distribution	  
based	  on	  race,	  education,	  and	  income	  categories	  were	  similar	  across	  GDM	  status.	  In	  terms	  of	  
proportion	  of	  the	  population	  at	  risk	  for	  diabetes,	  women	  with	  a	  history	  of	  GDM	  were	  more	  
likely	  than	  women	  without	  a	  history	  of	  GDM	  to	  have	  T2DM	  as	  indicated	  by:	  self-­‐reported	  
history	  of	  prediabetes	  (13.8%	  versus	  5.9%;	  p<0.0001),	  told	  by	  a	  healthcare	  professional	  (27.3%	  
versus	  12.5%;	  p<0.0001),	  HbA1c	  ≥	  6.5%	  (23.3%	  versus	  10.1%;	  p<0.0001),	  FPG	  ≥	  126mg/dL	  
(25.0%	  versus	  10.4%;	  p<0.0001),	  and	  OGTT	  ≥	  200	  mg/dL	  (13.8%	  versus	  7.4%;	  p=0.0244).	  
	   Of	  the	  n=315	  participants	  with	  a	  GDM	  history,	  n=111	  women	  (35.2%)	  presented	  with	  
current	  diagnosis	  of	  T2DM.	  In	  comparison,	  664	  participants	  (18%)	  without	  a	  history	  of	  GDM	  
presented	  with	  current	  diagnosis	  of	  T2DM.	  The	  proportion	  of	  women	  with	  and	  without	  a	  
history	  of	  GDM	  who	  developed	  T2DM	  is	  presented	  in	  Table	  2.	  Over	  half	  of	  the	  participants	  with	  
current	  diabetes	  were	  between	  the	  ages	  of	  45	  and	  69	  years.	  More	  than	  half	  of	  this	  population	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graduated	  from	  high	  school	  or	  had	  some	  college	  education.	  Approximately	  70%	  had	  less	  than	  a	  
$55,000	  annual	  income.	  Approximately	  85.7%	  and	  80.2%	  (p=0.0442)	  of	  the	  participants,	  with	  
and	  without	  a	  known	  history	  of	  GDM,	  respectfully,	  were	  overweight	  or	  obese	  (BMI	  ≥	  25	  kg/m2).	  
There	  were	  more	  women	  with	  a	  known	  history	  of	  hypertension	  among	  those	  without	  a	  known	  
history	  of	  GDM	  compared	  to	  women	  with	  a	  history	  of	  GDM	  (73.5%	  versus	  60%,	  p=0.0002).	  
4.2	  Univariate	  Analysis	  
	   Univariate	  analysis	  was	  conducted	  to	  determine	  the	  association	  between	  each	  
independent	  variable	  with	  GDM	  history	  and	  current	  T2DM	  status	  (Table	  2).	  Women	  with	  a	  
history	  of	  GDM	  had	  a	  2.49	  (CI:	  1.95-­‐3.18;	  p<0.0001)	  odds	  of	  subsequent	  T2DM	  compared	  to	  
those	  without	  a	  history	  of	  GDM.	  Subjects	  in	  the	  age	  groups	  of	  45-­‐69	  and	  70+	  years	  had	  much	  
increased	  odds	  ratios	  of	  T2DM,	  as	  evidenced	  by	  (OR=4.24;	  95%	  CI:	  3.34-­‐5.38;	  p<0.0001)	  and	  
(OR=6.99;	  95%	  CI:	  5.38-­‐9.08;	  p<0.0001),	  respectively.	  The	  odds	  of	  subsequent	  T2DM	  were	  
higher	  among	  non-­‐Hispanic	  Black	  (OR=1.59;	  95%	  CI:	  1.30-­‐1.93)	  and	  Hispanic-­‐Mexican	  origin	  
(OR=1.51;	  95%	  CI:	  1.23-­‐1.85)	  versus	  non-­‐Hispanic	  White	  origin.	  Women	  within	  the	  sample	  
population	  with	  a	  BMI	  ≥25	  kg/m2	  had	  a	  higher	  risk	  of	  T2DM	  compared	  to	  women	  with	  a	  BMI	  
<25	  kg/m2	  (OR=3.54;	  95%	  CI:	  2.83-­‐4.43).	  
4.3	  Multivariate	  Analysis	  
	   After	  adjusting	  for	  age,	  race,	  and	  BMI,	  women	  with	  a	  history	  of	  GDM	  had	  4.71	  (95%	  CI:	  
3.52-­‐6.28)	  higher	  odds	  of	  developing	  subsequent	  T2DM	  compared	  with	  women	  without	  a	  
history	  of	  GDM	  (Table	  4).	  Compared	  to	  non-­‐Hispanic	  White,	  participants	  of	  non-­‐Hispanic	  Black,	  
Mexican	  American,	  and	  non-­‐Hispanic	  Asian	  had	  1.92	  (95%	  CI:	  1.55-­‐2.40),	  1.90	  (95%	  CI:	  1.51-­‐
2.38),	  and	  1.95	  (95%	  CI:	  1.41-­‐2.69)	  greater	  odds	  of	  T2DM,	  respectively.	  Compared	  to	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participants	  with	  normal	  weight	  (BMI	  <	  25	  kg/m2),	  being	  overweight	  or	  obese	  (BMI	  ≥	  25	  kg/m2)	  
was	  associated	  with	  increased	  odds	  for	  subsequent	  T2DM	  (OR=2.74;	  95%	  CI:	  2.19-­‐3.51).	  
	   Table	  5	  shows	  the	  association	  between	  history	  of	  GDM	  and	  current	  T2DM	  status	  
stratified	  by	  age	  using	  multivariate	  analysis.	  The	  analysis	  was	  adjusted	  for	  race,	  BMI,	  history	  of	  
hypertension,	  HDL,	  LDL,	  total	  cholesterol,	  and	  triglyceride.	  In	  the	  age-­‐stratified	  analysis,	  women	  
between	  in	  the	  20-­‐44	  age	  group	  with	  a	  known	  history	  of	  GDM	  had	  3.02	  (95%	  CI:	  1.88-­‐4.85)	  
increased	  odds	  of	  T2DM,	  but	  was	  not	  significantly	  associated	  with	  T2DM	  in	  45-­‐69	  and	  70	  age	  
groups.	  Within	  the	  20-­‐44	  age	  group,	  women	  with	  HDL	  <	  40	  mg/dL	  had	  2.46	  (95%	  CI:	  1.65-­‐3.69)	  
increased	  odds	  of	  T2DM	  than	  those	  with	  HDL	  ≥	  40	  mg/dL.	  Participants	  between	  the	  ages	  of	  45	  
and	  69	  years	  had	  increased	  odds	  of	  T2DM	  if	  they	  had	  a	  history	  of	  hypertension	  (OR=1.72;	  95%	  
CI:	  1.41-­‐2.10),	  elevated	  total	  cholesterol	  (OR=1.89;	  95%	  CI:	  1.22-­‐2.94)	  and	  triglyceride	  levels	  
(OR=1.54;	  95%	  CI:	  1.54-­‐2.21).	  Women	  in	  the	  70+	  age	  group	  had	  increased	  odds	  of	  T2DM	  if	  they	  
had	  a	  known	  history	  of	  hypertension	  (OR=4.92;	  95%	  CI:	  3.73-­‐6.49).	  
	   Table	  6	  shows	  the	  association	  between	  history	  of	  GDM	  and	  current	  T2DM	  status	  
stratified	  by	  race	  after	  adjusting	  for	  age,	  BMI,	  history	  of	  hypertension,	  HDL,	  LDL,	  total	  
cholesterol,	  and	  triglyceride.	  Women	  of	  non-­‐Hispanic	  Asian	  and	  Other	  race	  origin	  with	  a	  history	  
of	  GDM	  were	  associated	  with	  1.68	  (95%	  CI:	  0.94-­‐3.00)	  and	  1.86	  (95%	  CI:	  0.75-­‐4.60)	  increased	  
odds	  of	  T2DM	  compared	  to	  women	  without	  a	  known	  history	  of	  GDM.	  Non-­‐Hispanic	  White	  
women	  in	  the	  70+	  age	  category	  were	  associated	  with	  3.03	  (95%	  CI:	  2.23-­‐4.13)	  increased	  odds	  of	  
T2DM	  than	  those	  in	  the	  20-­‐44	  age	  category.	  Non-­‐Hispanic	  Black	  and	  Mexican	  American	  
participants	  with	  BMI	  ≥	  25	  kg/m2	  have	  2.33	  (95%	  CI:	  1.73-­‐3.15)	  and	  2.29	  (95%	  CI:	  1.71-­‐3.06)	  
greater	  odds	  of	  T2DM	  than	  those	  with	  normal	  weight	  (BMI	  <	  25	  kg/m2).	  Non-­‐Hispanic	  Black	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participants	  with	  a	  history	  of	  hypertension	  (OR=2.16;	  95%	  CI:	  1.68-­‐2.80)	  and	  elevated	  LDL	  levels	  
(OR=1.95;	  95%	  CI:	  1.03-­‐3.72)	  were	  associated	  with	  increased	  odds	  of	  T2DM.	  Non-­‐Hispanic	  
White	  participants	  with	  elevated	  total	  cholesterol	  (OR=	  1.88;	  95%	  CI:	  1.20-­‐2.95)	  and	  triglyceride	  
(OR=1.58;	  95%	  CI:	  1.11-­‐2.25)	  levels	  were	  associated	  with	  increased	  odds	  of	  T2DM.	  
	   Table	  7	  shows	  the	  association	  between	  history	  of	  GDM	  and	  current	  T2DM	  status	  
stratified	  by	  BMI	  after	  adjusting	  for	  age,	  race,	  hypertension,	  HDL,	  LDL,	  total	  cholesterol,	  and	  
triglyceride.	  Overweight	  and	  obese	  women	  with	  a	  history	  of	  GDM	  were	  associated	  with	  2.51	  
(95%	  CI:	  1.49-­‐4.23)	  increased	  odds	  of	  T2DM	  compared	  to	  women	  without	  a	  known	  history	  of	  
GDM.	  Overweight	  and	  obese	  women	  of	  Mexican	  American	  (OR=2.33;	  95%	  CI:	  1.73-­‐3.15)	  and	  
non-­‐Hispanic	  Black	  origin	  (OR=2.29;	  95%	  CI:	  1.71-­‐3.06)	  were	  associated	  with	  greater	  odds	  of	  
T2DM	  than	  those	  of	  normal	  weight.	  Non-­‐Hispanic	  Asian	  participants	  with	  normal	  weight	  were	  
associated	  with	  increased	  odds	  for	  T2DM	  compared	  to	  non-­‐Hispanic	  Whites	  (OR=4.55;	  95%	  CI:	  
3.15-­‐6.56).	  Overweight	  and	  obese	  participants	  with	  a	  history	  of	  hypertension	  (OR=2.33;	  95%	  CI:	  
1.68-­‐2.80),	  low	  HDL	  levels	  (OR=2.95;	  95%	  CI:	  1.66-­‐5.24),	  elevated	  LDL	  levels	  (OR=3.01;	  95%	  CI:	  
1.63-­‐5.57),	  and	  elevated	  triglyceride	  levels	  (OR=1.90;	  95%	  CI:	  1.16-­‐3.11)	  were	  associated	  with	  









Discussion	  and	  Conclusion	  
5.1	  Discussion	  
	   This	  study	  sought	  to	  determine	  the	  association	  between	  having	  a	  history	  of	  GDM	  and	  
current	  T2DM	  status	  among	  American	  women.	  Previous	  literature	  revealed	  women	  with	  a	  
history	  of	  GDM	  have	  an	  increased	  risk	  of	  developing	  T2DM,	  but	  the	  risk	  varied	  between	  studies.	  
The	  reported	  incidence	  rate	  of	  T2DM	  following	  GDM	  history	  varied	  from	  2.6-­‐70	  %	  with	  a	  follow	  
up	  period	  of	  6	  weeks	  to	  28	  years	  postpartum.53	  The	  succeeding	  aim	  of	  the	  study	  was	  to	  
determine	  if	  the	  association	  differed	  based	  on	  participant	  age,	  race,	  and	  BMI.	  The	  influence	  of	  
variables	  such	  as	  race,	  age,	  body	  mass	  index,	  hypertension,	  HDL,	  LDL,	  total	  cholesterol,	  and	  
triglycerides	  were	  also	  examined.	  	  
	   NHANES	  was	  used	  for	  this	  study	  because	  it	  is	  a	  national	  representation	  of	  the	  non-­‐
institutionalized	  population	  of	  residents	  in	  the	  U.S.	  The	  NHANES	  2011-­‐2012	  and	  2013-­‐2014	  
datasets	  contained	  the	  latest	  released	  data.	  Based	  on	  the	  NHANES	  2011-­‐2014	  datasets,	  
approximately	  34.2%	  of	  women	  with	  a	  self-­‐reported	  history	  of	  GDM	  developed	  T2DM.	  When	  
controlled	  for	  age,	  race,	  and	  BMI,	  women	  with	  a	  history	  of	  GDM	  had	  a	  strong	  association	  for	  
developing	  subsequent	  T2DM.	  These	  findings	  support	  previous	  evidence	  that	  GDM	  increases	  
the	  risk	  of	  developing	  T2DM	  in	  subsequent	  years.56	  	  
	   When	  stratified	  by	  age,	  women	  with	  a	  history	  of	  GDM	  between	  the	  ages	  of	  20-­‐44	  years	  
had	  3.02	  (95%	  CI:	  1.88-­‐4.85)	  increased	  odds	  of	  subsequent	  T2DM	  than	  women	  without	  a	  
history	  of	  GDM.	  Previous	  literature	  suggests	  the	  progression	  to	  T2DM	  increases	  sharply	  within	  
the	  first	  5	  years	  postpartum	  and	  then	  plateaus	  after	  10	  years.53,62	  The	  WHO	  classifies	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reproductive	  age	  between	  the	  ages	  of	  15	  and	  44	  years.63	  There	  may	  be	  a	  greater	  odds	  ratio	  in	  
the	  20-­‐44	  age	  group	  because	  these	  women	  are	  within	  the	  reproductive	  age	  range.	  These	  results	  
were	  different	  that	  what	  I	  expected.	  Earlier	  studies	  showed	  the	  risk	  of	  T2DM	  to	  increase	  as	  an	  
individual	  matures.17,	  19	  I	  expected	  the	  ORs	  of	  developing	  subsequent	  T2DM	  to	  increase	  as	  the	  
age	  categories	  to	  increase.	  	  
	   Previous	  studies	  examined	  the	  relationship	  between	  non-­‐Hispanic	  White,	  non-­‐Hispanic	  
Black,	  and	  Hispanics	  races	  with	  GDM	  and	  T2DM,	  but	  there	  is	  limited	  information	  about	  the	  non-­‐
Hispanic	  Asian	  population	  living	  in	  the	  United	  States.	  NHANES	  started	  stratifying	  race	  to	  include	  
Non-­‐Hispanic	  Asians	  for	  the	  first	  time	  in	  the	  2011-­‐2012	  two-­‐year	  cycle.	  The	  multivariate	  
analysis	  used	  to	  examine	  the	  associated	  of	  GDM	  history	  and	  current	  T2DM	  status	  did	  not	  show	  
statistical	  significance	  when	  stratified	  by	  race.	  The	  results	  indicated	  that	  women	  of	  non-­‐
Hispanic	  Asian	  (OR=1.68;	  95%	  CI:	  0.94-­‐3.00)	  and	  Other	  race	  (OR=1.86;	  95%	  CI:	  0.75-­‐4.60)	  origin	  
with	  a	  history	  of	  GDM	  have	  increased	  odds	  of	  developing	  subsequent	  T2DM,	  but	  the	  odds	  
ratios	  does	  not	  show	  statistical	  significance.	  Previous	  literature	  indicates	  there	  are	  racial	  and	  
ethnic	  differences	  in	  the	  association	  between	  GDM	  history	  and	  risk	  for	  T2DM.64	  One	  would	  
expect	  to	  see	  increased	  ORs	  among	  the	  minority	  groups.65	  
	   When	  stratified	  by	  BMI,	  overweight	  and	  obese	  individuals	  with	  a	  history	  of	  GDM	  had	  2.51	  
(95%	  CI:	  1.49-­‐4.23)	  increased	  odds	  to	  currently	  have	  T2DM	  than	  overweight	  and	  obese	  women	  
without	  GDM.	  These	  results	  are	  consistent	  with	  previous	  literature.35,	  53	  Individuals	  with	  higher	  
BMIs	  are	  at	  greater	  risk	  of	  T2DM.	  
	   The	  risk	  of	  T2DM	  is	  multifactorial	  so	  it	  must	  also	  be	  examined	  as	  such.	  Non-­‐Hispanic	  Black	  
and	  Mexican	  American	  has	  a	  2.33	  (95%	  CI:	  1.73-­‐3.15)	  and	  2.29	  (95%	  CI:	  1.71-­‐3.06),	  respectively,	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increased	  odds	  of	  T2DM	  if	  their	  BMI	  ≥	  25	  kg/m2.	  There	  was	  also	  a	  significant	  association	  
between	  elevated	  BMI	  (≥	  25	  kg/m2)	  with	  low	  HDL,	  high	  total	  cholesterol,	  and	  high	  triglyceride	  
levels.	  Cholesterol	  levels,	  especially	  HDL	  <	  40	  mg/dL,	  LDL	  >	  160	  mg/dL,	  and	  total	  cholesterol	  
>200	  mg/dL,	  were	  also	  statistical	  significant	  for	  women	  with	  a	  BMI	  ≥	  25	  kg/m2,	  indicating	  
women	  with	  any	  of	  the	  listed	  conditions	  are	  at	  increased	  odds	  of	  developing	  T2DM.	  
Hypertension	  showed	  statistical	  significance	  among	  women	  45	  years	  and	  older,	  non-­‐Hispanic	  
Black,	  Other	  Race,	  and	  with	  a	  BMI	  ≥	  25	  kg/m2.	  
5.2	  Limitations	  
	   This	  was	  a	  cross-­‐sectional	  study	  using	  secondary	  data	  from	  NHANES	  2011-­‐2014.	  Cross-­‐
sectional	  studies	  by	  definition	  only	  provide	  a	  snapshot	  of	  the	  population	  and	  can	  only	  show	  
association,	  not	  causal	  inferences.	  A	  limitation	  with	  NHANES	  is	  responses	  to	  the	  questionnaires	  
were	  self-­‐reported.	  There	  may	  have	  been	  recall	  or	  self-­‐reported	  bias.	  Diabetes	  was	  not	  
classified	  based	  on	  type	  (1	  or	  2)	  in	  the	  diabetes	  questionnaire.	  T2DM	  was	  classified,	  based	  on	  
the	  participant’s	  responses	  to	  the	  questions	  noted	  in	  the	  methods	  section.	  Women	  with	  at	  least	  
one	  of	  the	  laboratory	  measures	  that	  met	  the	  diabetes	  criteria	  were	  considered	  new	  diabetics	  
for	  this	  study.	  Repeat	  testing	  would	  have	  been	  required	  to	  be	  truly	  diagnostic.12	  NHANES	  data	  
provided	  a	  nationally	  representative	  sample,	  but	  the	  results	  may	  not	  be	  representative	  of	  the	  
general	  population	  due	  to	  the	  sampling	  method.	  The	  results	  of	  this	  study	  should	  also	  be	  
carefully	  interpreted	  due	  to	  the	  lack	  of	  confounding	  factors,	  such	  as	  smoking	  status,	  diet,	  and	  




5.3	  Implications	  of	  Findings	  
	   Women	  between	  the	  ages	  of	  20	  and	  44	  years	  with	  a	  history	  of	  GDM	  have	  a	  strong	  
association	  with	  subsequent	  T2DM.	  The	  time	  after	  delivery	  is	  most	  important	  for	  preventing	  
T2DM	  from	  developing.	  Clinical	  implications	  from	  our	  study	  include	  the	  need	  for	  clinicians	  who	  
manage	  the	  care	  of	  postpartum	  women	  with	  a	  history	  of	  GDM	  to	  be	  cognizant	  of	  the	  elevated	  
risk	  of	  T2DM.	  These	  clinicians	  can	  provide	  these	  women	  with	  additional	  information	  and	  
resources	  for	  postpartum	  interventions	  to	  reduce	  modifiable	  risks	  of	  T2DM,	  such	  as	  BMI,	  which	  
also	  has	  a	  strong	  association.	  	  	  	  
5.4	  Conclusion	  
	   This	  analysis	  provides	  further	  insight	  on	  the	  role	  of	  GDM	  and	  its	  risks	  for	  the	  development	  
of	  subsequent	  T2DM.	  The	  study	  shows	  that	  women	  with	  increased	  risks	  of	  T2DM	  are:	  between	  
the	  ages	  of	  20	  and	  44	  years	  and	  have	  a	  BMI	  ≥	  25	  kg/m2.	  The	  result	  of	  this	  study	  suggests	  the	  
need	  for	  health	  promotion	  and	  prevention	  effects	  tailored	  to	  women	  with	  a	  history	  of	  GDM	  
within	  these	  populations.	  Early	  intervention	  post-­‐pregnancy	  may	  help	  prevent	  women	  with	  a	  
history	  of	  GDM	  from	  developing	  T2DM.	  Future	  studies	  should	  expand	  on	  this	  study	  and	  include	  
other	  confounding	  factors	  not	  mentioned	  in	  this	  study.	  Future	  research	  should	  also	  include	  
examining	  future	  NHANES	  datasets	  in	  a	  similar	  fashion	  to	  determine	  trend	  of	  association	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Table	  1:	  Basic	  Characteristics	  of	  Study	  Population	  Based	  on	  GDM	  History	  
	   GDM	  (%)	   No	  GDM	  (%)	   P-­‐value	  
Total	   n=315	   n=3691	   	  	  
Age	  (years)	   	  	   	  	   	  	  
20-­‐44	   56.2	   32.2	   	  	  
45-­‐69	   40.6	   47.6	   <0.0001	  
70+	   3.2	   20.2	   	  	  
Race	   	  	   	  	   	  	  
NH	  White	   35.3	   41.7	   	  	  
NH	  Black	   27.3	   21.4	   	  	  
Mexican	  American	   18.7	   24.6	   0.0003	  
NH	  Asian	   14.9	   9.6	   	  	  
Other	  Race	   3.8	   2.7	   	  	  
Education	   	  	   	  	   	  	  
Less	  than	  High	  School	   21.0	   23.7	   	  	  
HS	  Graduate	  or	  some	  college	   55.6	   54.3	   0.5303	  
College	  Graduate	  or	  more	   23.5	   22.1	   	  	  
Income	   	  	   	  	   	  	  
Less	  than	  $25,000	   26.6	   35.1	   	  	  
$25,000	  to	  $54,999	   31.6	   30.4	   0.0186	  
$55,000	  to	  $74,999	   12.8	   10.1	   	  	  
$75,000	  or	  more	   29.0	   24.5	   	  	  
BMI	  (kg/m2)	   	  	   	  	   	  	  
BMI	  <	  25	  kg/m2	   20.0	   29.1	   	  	  
BMI	  ≥	  25	  kg/m2	   80.0	   70.9	   0.0006	  
History	  of	  Hypertension	   	  	   	  	   	  	  
No	   63.4	   56.6	   	  	  
Yes	   36.6	   43.4	   0.0206	  
HDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
	  HDL	  ≥40	  mg/dL	  	   80.7	   90.2	   	  	  
HDL	  <40	  mg/dL	   19.3	   9.8	   <0.0001	  
LDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
LDL	  <160	  mg/dL	   93.5	   90.6	   	  	  
LDL	  ≥160	  mg/dL	   6.5	   9.4	   0.2597	  
Total	  Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
Tchol	  <	  240	  mg/dL	   88.0	   86.0	   	  	  
Tchol	  ≥240	  mg/dL	   12.0	   14.0	   0.3282	  
Triglyceride	  (mg/dL)	   	  	   	  	   	  	  
Trig	  <200	  mg/dL	   81.9	   91.1	   	  	  
Trig	  ≥200	  mg/dL	   18.1	   8.9	   0.0003	  
Diabetes	   	  	   	  	   	  	  
Told	  you	  had	  Prediabetes?	   	  	   	  	   	  	  
 36 
No	  	   86.2	   94.1	   	  	  
Yes	   13.8	   5.9	   <0.0001	  
Told	  you	  were	  diabetic?	   	  	   	  	   	  	  
No	   72.7	   87.5	   	  	  
Yes	   27.3	   12.5	   <0.0001	  
Take	  diabetic	  pills	  to	  lower	  
blood	  sugar?	   	  	   	  	   	  	  
No	   53.4	   52.1	   	  	  
Yes	   46.6	   47.9	   0.7902	  
Glycohemoglobin	  (%)	   	  	   	  	   	  	  
HbA1c	  <6.5	  %	   76.7	   89.9	   	  	  
HbA1c	  ≥6.5	  %	   23.3	   10.1	   <0.0001	  
FPG	  mg/dL	   	  	   	  	   	  	  
FPG	  <126	  mg/dL	   75.0	   89.6	   	  	  
FPG	  ≥126	  mg/dL	   25.0	   10.4	   <0.0001	  
OGTT	  mg/dL	   	  	   	  	   	  	  
OGTT	  <200	  mg/dL	   86.2	   92.6	   	  	  






























Table	  2:	  The	  Demographic	  and	  Metabolic	  Characteristics	  of	  Current	  T2DM	  Status	  by	  GDM	  History	  
	  	   GDM	  (%)	   No	  GDM	  (%)	   P-­‐value	  
(n=775)	   (n=111)	   (n=664)	   	  	  
Age	  (years)	   	  	   	  	   	  	  
20-­‐44	   34.2	   7.8	   <0.0001	  
45-­‐69	   58.6	   55.7	   	  	  
70+	   7.2	   36.4	   	  	  
Race	   	  	   	  	   	  	  
NH	  White	   36.0	   34.0	   	  	  
NH	  Black	   31.5	   24.4	   0.2547	  
Mexican	  American	   20.7	   30.6	   	  	  
NH	  Asian	   9.9	   8.9	   	  	  
Other	  Race	   1.8	   2.1	   	  	  
Education	   	  	   	  	   	  	  
Less	  than	  High	  School	   29.7	   36.4	   0.3494	  
HS	  Graduate	  or	  some	  College	   59.5	   52.4	   	  	  
College	  or	  more	   10.8	   11.1	   	  	  
Income	   	  	   	  	   	  	  
Less	  than	  $25,000	   32.7	   46.2	   	  	  
$25,000-­‐$54,999	   31.8	   31.0	   0.0188	  
$55,000-­‐$74,999	   14.0	   9.8	   	  	  
$75,000	  or	  more	   21.5	   13.0	   	  	  
BMI	  (kg/m2)	   	  	   	  	   	  	  
BMI	  <	  25	  kg/m2	   14.3	   19.8	   	  
BMI	  ≥	  25	  kg/m2	   85.7	   80.2	   0.0442	  	  
Hypertension	   	  	   	  	   	  	  
No	   40.0	   26.5	   	  	  
Yes	   60.0	   73.5	   0.0002	  
HDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
	  HDL	  ≥40	  mg/dL	  	   78.9	   86.2	   	  	  
HDL	  <40	  mg/dL	   21.1	   13.8	   0.0501	  
LDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
LDL	  <160	  mg/dL	   93.0	   89.8	   	  	  
LDL	  ≥160	  mg/dL	   7.0	   10.2	   0.4526	  
Total	  Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
Tchol	  <	  240	  mg/dL	   85.3	   86.2	   	  	  
Tchol	  ≥240	  mg/dL	   14.7	   13.8	   0.8176	  
Triglyceride	  (mg/dL)	   	  	   	  	   	  	  
Trig	  <200	  mg/dL	   72.1	   83.3	   	  	  
Trig	  ≥200	  mg/dL	   27.9	   16.7	   0.0384	  
Diabetes	   	  	   	  	   	  	  
 38 
Told	  you	  had	  Prediabetes?	   	  	   	  	   	  	  
No	  	   63.2	   76.6	   	  	  
Yes	   36.8	   23.4	   0.2599	  
Told	  you	  were	  diabetic?	   	  	   	  	   	  	  
No	   22.5	   30.5	   	  	  
Yes	   77.5	   69.5	   0.0888	  
Take	  diabetic	  pills	  to	  lower	  
blood	  sugar?	   	  	   	  	   	  	  
No	   36.7	   32.4	   	  	  
Yes	   63.3	   67.6	   0.4011	  
Glycohemoglobin	  (%)	   	  	   	  	   	  	  
HbA1c	  <6.5%	   35.5	   43.6	   	  	  
HbA1c	  ≥6.5%	   64.5	   56.4	   0.1115	  
Fasting	  Plasma	  Glucose	  (mg/dL)	   	  	   	  	   	  	  
FPG	  <126	  mg/dL	   41.0	   48.4	   	  	  
FPG	  ≥126	  mg/dL	   59.0	   51.6	   0.2837	  
OGTT	  (mg/dL)	   	  	   	  	   	  	  
OGTT	  <200	  mg/dL	   27.8	   25.0	   	  	  



























Table	  3:	  Univariate	  Association	  of	  GDM	  History	  and	  Current	  T2DM	  Status	  
Variables	   OR	   95%	  CI	   P-­‐value	  
Gestational	  DM	   	  	   	  	   	  	  
No	   Ref	   Ref	   Ref	  
Yes	   2.49	   (1.95-­‐3.18)	   <0.0001	  
Age	  (year)	   	  	   	  	   	  	  
20-­‐44	   Ref	   Ref	   Ref	  
45-­‐69	   4.24	   (3.34-­‐5.38)	   <0.001	  
70+	   6.99	   (5.38-­‐9.08)	   <0.001	  
Race	   	  	   	  	   	  	  
NH	  White	   Ref	   Ref	   Ref	  
NH	  Black	   1.59	   (1.30-­‐1.93)	   <0.0001	  
Mexican	  American	   1.51	   (1.23-­‐1.85)	   <0.0001	  
NH	  Asian	   1.10	   (0.82-­‐1.46)	   0.5339	  
Other	   0.87	   (0.50-­‐1.50)	   0.6078	  
BMI	  (kg/m2)	   	  	   	  	   	  	  
BMI<25	  kg/m2	   Ref	   Ref	   Ref	  





























Table	  4:	  Multivariate	  Association	  of	  GDM	  History	  and	  Current	  T2DM	  Status	  
Variables	   OR	   95%	  CI	   P-­‐value	  
Gestational	  DM	   	  	   	  	   	  	  
No	   Ref	   Ref	   Ref	  
Yes	   4.71	   (3.52-­‐6.28)	   <0.0001	  
Age	  (years)	   	  	   	  	   	  	  
20-­‐44	   Ref	   Ref	   Ref	  
45-­‐69	   5.35	   (4.13-­‐6.94)	   <0.0001	  
70+	   12.68	   (9.41-­‐17.09)	   <0.0001	  
Race	   	  	   	  	   	  	  
NH	  White	   Ref	   Ref	   Ref	  
NH	  Black	   1.92	   (1.55-­‐2.40)	   <0.0001	  
Mexican	  American	   1.90	   (1.51-­‐2.38)	   <0.0001	  
NH	  Asian	   1.95	   (1.41-­‐2.69)	   0.0026	  
Other	   1.56	   (0.87-­‐2.81)	   0.1359	  
BMI	  (kg/m2)	   	  	   	  	   	  	  
BMI<25	  kg/m2	   Ref	   Ref	   Ref	  





























Table	  5:	  Multivariate	  Association	  of	  GDM	  History	  and	  Current	  T2DM	  Status	  Stratified	  by	  Age	  
	  	   Age	  
	  	   20-­‐44	  Years	   45-­‐69	  Years	   70+	  Years	  
Variables	   OR	  (95%	  CI)	   OR	  (95%	  CI)	   OR	  (95%	  CI)	  
Gestational	  DM	   	  	   	  	   	  	  
No	   Ref	   Ref	   Ref	  
Yes	   3.02	  (1.88-­‐4.85)	   0.71	  (0.50-­‐1.03)	   0.13	  (0.05-­‐0.36)	  
Race	   	  	   	  	   	  	  
NH	  White	   Ref	   Ref	   Ref	  
NH	  Black	   1.60	  (1.19-­‐2.14)	   1.52	  (1.18-­‐1.95)	   0.28	  (0.20-­‐0.40)	  
Mexican	  American	   1.06	  (0.80-­‐1.42)	   1.69	  (1.31-­‐2.17)	   0.39	  (0.27-­‐0.55)	  
NH	  Asian	   1.15	  (0.79-­‐1.68)	   1.74	  (1.23-­‐2.45)	   0.31	  (0.18-­‐0.52)	  
Other	  Race	   1.88	  (0.93-­‐3.79)	   1.23	  (0.65-­‐2.31)	   0.31	  (0.12-­‐0.83)	  
BMI	  kg/m2	   	  	   	  	   	  	  
BMI	  <25	  kg/m2	   Ref	   Ref	   Ref	  
BMI	  ≥	  25	  kg/m2	   1.06	  (0.82-­‐1.37)	   1.19	  (0.95-­‐1.50)	   0.68	  (0.50-­‐0.83)	  
History	  of	  Hypertension	   	  	   	  	   	  	  
No	   Ref	   Ref	   Ref	  
Yes	   0.15	  (0.11-­‐0.19)	   1.72	  (1.41-­‐2.10)	   4.92	  (3.73-­‐6.49)	  
HDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
	  HDL	  ≥40	  mg/dL	   Ref	   Ref	   Ref	  
HDL	  <40	  mg/dL	   2.46	  (1.65-­‐3.69)	   0.77	  (0.54-­‐1.11)	   0.37	  (0.20-­‐0.69)	  
LDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	   	  	  
LDL	  <160	  mg/dL	   Ref	   Ref	   Ref	  
LDL	  ≥160	  mg/dL	   0.88	  (0.45-­‐1.72)	   1.09	  (0.66-­‐1.79)	   0.96	  (0.50-­‐1.84)	  
Total	  Cholesterol	  
(mg/dL)	   	  	   	  	   	  	  
Tchol	  <	  240	  mg/dL	   Ref	   Ref	   Ref	  
Tchol	  ≥240	  mg/dL	   0.25	  (0.14-­‐0.45)	   1.89	  (01.22-­‐2.94)	  	   1.37	  (0.78-­‐2.40)	  
Triglyceride	  (mg/dL)	   	  	   	   	  	  
Trig	  <200	  mg/dl	   Ref	   Ref	   Ref	  




Table	  6:	  Multivariate	  Association	  of	  GDM	  History	  and	  Current	  T2DM	  Status	  Stratified	  by	  Race	  
	  	   Race	  
	  	   NH	  White	   NH	  Black	  
Mexican	  
American	   NH	  Asian	   Other	  
Variables	   OR	  (95%CI)	   OR	  (95%CI)	   OR	  (95%CI)	   OR	  (95%CI)	   OR	  (95%CI)	  
Gestational	  DM	   	  	   	  	   	  	   	  	   	  	  
No	   Ref	   Ref	   Ref	   Ref	   Ref	  
Yes	   0.83	  (0.59-­‐1.26)	   0.81	  (0.52-­‐1.27)	   1.02	  (0.67-­‐1.55)	   1.68	  (0.94-­‐3.00)	   1.86	  (0.75-­‐4.60)	  
Age	  (years)	   	  	   	  	   	  	   	  	   	  	  
20-­‐44	   Ref	   Ref	   Ref	   Ref	   Ref	  
45-­‐69	   0.98	  (0.78-­‐1.23)	   0.80	  (0.61-­‐1.05)	   1.25	  (0.96-­‐1.63)	   1.13	  (0.78-­‐1.64)	   0.68	  (0.34-­‐1.39)	  
70+	   3.03	  (2.23-­‐4.13)	   0.34	  (0.23-­‐0.51)	   0.72	  (0.49-­‐1.07)	   0.53	  (0.30-­‐0.94)	   0.41	  (0.14-­‐1.22)	  
BMI	  (kg/m2)	   	  	   	  	   	  	   	  	   	  	  
BMI	  <25	  kg/m2	   Ref	   Ref	   Ref	   Ref	   Ref	  
BMI	  ≥	  25	  kg/m2	   0.82	  (0.66-­‐1.02)	   2.33	  (1.73-­‐3.15)	   2.29	  (1.71-­‐3.06)	   0.16	  (0.11-­‐0.22)	   0.54	  (0.28-­‐1.04)	  
History	  of	  
Hypertension	   	  	   	  	   	  	   	  	   	  	  
No	   Ref	   Ref	   Ref	   Ref	   Ref	  
Yes	   0.85	  (0.60-­‐1.06)	   2.16	  (1.68-­‐2.80)	   0.59	  (0.46-­‐0.77)	   0.80	  (0.54-­‐1.17)	   1.62	  (0.81-­‐3.24)	  
HDL-­‐Chol	  
(mg/dL)	   	  	   	  	   	  	   	  	   	  	  
	  HDL	  ≥40	  mg/dL	  	   Ref	   Ref	   Ref	   Ref	   Ref	  
HDL	  <40	  mg/dL	   1.40	  (0.98-­‐2.01)	   0.70	  (0.45-­‐1.10)	   0.95	  (0.63-­‐1.45)	   0.73	  (0.35-­‐1.53)	   1.20	  (0.43-­‐3.32)	  
LDL-­‐Chol	  (mg/dL)	   	  	   	  	   	  	   	  	   	  	  
LDL	  <160	  mg/dL	   Ref	   Ref	   Ref	   Ref	   Ref	  




(mg/dL)	   	  	   	  	   	  	   	  	   	  	  
Tchol	  <	  240	  
mg/dL	   Ref	   Ref	   Ref	   Ref	   Ref	  
Tchol	  ≥240	  
mg/dL	   1.88	  (1.20-­‐2.95)	   0.50	  (0.27-­‐0.94)	   1.17	  (0.69-­‐1.7)	   0.40	  (0.17-­‐0.97)	   0.39	  (0.07-­‐2.32)	  
Triglyceride	  
(mg/dL)	   	   	   	  	   	  	   	  	  
Trig	  <200	  mg/dL	   Ref	   Ref	   Ref	   Ref	   Ref	  









Table	  7:	  Multivariate	  Association	  of	  GDM	  History	  and	  Current	  T2DM	  Status	  Stratified	  by	  BMI	  
	  	   BMI	  
	  	   <	  25	  kg/m2	   ≥	  25	  kg/m2	  
Variables	   OR	   OR	  
Gestational	  DM	   	  	   	  	  
No	   Ref	   Ref	  
Yes	   0.40	  (0.24-­‐0.67)	   2.51	  (1.49-­‐4.23)	  
Age	  (years)	   	  	   	  	  
20-­‐44	   Ref	   Ref	  
45-­‐69	   0.95	  (0.73-­‐1.25)	   1.05	  (0.80-­‐1.38)	  
70+	   1.44	  (1.01-­‐2.04)	   0.70	  (0.49-­‐0.99)	  
Race	   	  	   	  	  
NH	  White	   Ref	   Ref	  
Hispanic	   0.45	  (0.33-­‐0.62)	   2.22	  (1.61-­‐3.07)	  
NH	  Black	   0.47	  (0.34-­‐0.64)	   2.12	  (1.55-­‐2.90)	  
NH	  Asian	   4.55	  (3.15-­‐6.56)	   0.22	  (0.15-­‐0.32)	  
Other	  Race	   1.65	  (0.85-­‐3.24)	   0.61	  (0.31-­‐1.18)	  
History	  of	  Hypertension	   	  	   	  	  
No	   Ref	   Ref	  
Yes	   0.43	  (0.33-­‐0.56)	   2.33	  (1.79-­‐3.02)	  
HDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	  
	  HDL	  ≥40	  mg/dL	  	   Ref	   Ref	  
HDL	  <40	  mg/dL	   0.34	  (0.19-­‐0.60)	   2.95	  (1.66-­‐5.24)	  
LDL-­‐Cholesterol	  (mg/dL)	   	  	   	  	  
LDL	  <160	  mg/dL	   Ref	   Ref	  
LDL	  ≥160	  mg/dL	   0.33	  (0.18-­‐0.62)	   3.01	  (1.63-­‐5.57)	  
Total	  Cholesterol	  (mg/dL)	   	  	   	  	  
Tchol	  <	  240	  mg/dL	   Ref	   Ref	  
Tchol	  ≥240	  mg/dL	   1.69	  (1.03-­‐2.79)	   0.59	  (0.36-­‐0.98)	  
Triglyceride	  (mg/dL)	   	  	   	  	  
Trig	  <200	  mg/dL	   Ref	   Ref	  
Trig	  ≥200	  mg/dL	   0.53	  (0.32-­‐0.86)	   1.90	  (1.16-­‐3.11)	  
	  
	  
	  
